Literature DB >> 19363633

Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus.

Laura B Zahodne1, Michael S Okun, Kelly D Foote, Hubert H Fernandez, Ramon L Rodriguez, Samuel S Wu, Lindsey Kirsch-Darrow, Charles E Jacobson, Christian Rosado, Dawn Bowers.   

Abstract

While deep brain stimulation (DBS) surgery is a well-accepted treatment for Parkinson disease (PD) that improves overall quality of life (QoL), its effects across different domains of QoL are unclear. The study reported here directly compared the effects of unilateral DBS in subthalamic nucleus (STN) or globus pallidus (GPi) on QoL in 42 non-demented patients with medication-refractory PD. Patients were enrolled in the COMPARE trial, a randomized clinical trial of cognitive and mood effects of STN versus GPi DBS conducted at the University of Florida Movement Disorders Center. Patients underwent motor, mood, verbal fluency and QoL (Parkinson disease questionnaire: PDQ-39) measures before and 6 months following surgery. Groups experienced motor and mood improvements that did not differ by target. Patients with STN DBS evidenced a slight decrement on letter fluency. On average, all patients endorsed better overall QoL after surgery. However, despite similar motor and mood improvements, GPi patients improved more than STN patients (38 vs. 14%, respectively; P = 0.03). Patients reported better QoL on subscales of mobility, activities of daily living (ADLs), emotional well-being, stigma, cognition and discomfort, but not on those of social support and communication. Improvements on the mobility, ADLs, stigma and social support subscales were greater amongst GPi patients. In regression analyses, only depression changes independently predicted changes in overall QoL as well as emotional well-being and social support changes. Within the STN group only, declining category fluency scores correlated with poorer QoL on the communication subscale. Unilateral DBS in both STN and GPi improved QoL overall and in disparate domains 6 months after surgery. Patients receiving GPi DBS reported greater improvements that cannot be explained by differential mood or motor effects; however, verbal fluency changes may have partially contributed to lesser QoL improvements amongst STN patients.

Entities:  

Mesh:

Year:  2009        PMID: 19363633      PMCID: PMC3045861          DOI: 10.1007/s00415-009-5121-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

Review 1.  Deep brain stimulation: neuropsychological and neuropsychiatric issues.

Authors:  Valerie Voon; Cynthia Kubu; Paul Krack; Jean-Luc Houeto; Alexander I Tröster
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

Review 2.  Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications.

Authors:  Atchar Sudhyadhom; Frank J Bova; Kelly D Foote; Christian A Rosado; Lindsey Kirsch-Darrow; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

3.  Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.

Authors:  Karsten Witt; Christine Daniels; Julia Reiff; Paul Krack; Jens Volkmann; Markus O Pinsker; Martin Krause; Volker Tronnier; Manja Kloss; Alfons Schnitzler; Lars Wojtecki; Kai Bötzel; Adrian Danek; Rüdiger Hilker; Volker Sturm; Andreas Kupsch; Elfriede Karner; Günther Deuschl
Journal:  Lancet Neurol       Date:  2008-06-04       Impact factor: 44.182

4.  Neurosurgery in Parkinson disease: a distressed mind in a repaired body?

Authors:  M Schüpbach; M Gargiulo; M L Welter; L Mallet; C Béhar; J L Houeto; D Maltête; V Mesnage; Y Agid
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

5.  Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?

Authors:  Aline Gronchi-Perrin; Sarah Viollier; Joseph Ghika; Pierre Combremont; Jean-Guy Villemure; Julien Bogousslavsky; Pierre R Burkhard; François Vingerhoets
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

6.  Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Authors:  Valerie C Anderson; Kim J Burchiel; Penelope Hogarth; Jacques Favre; John P Hammerstad
Journal:  Arch Neurol       Date:  2005-04

7.  Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease.

Authors:  Jerzy L Slowinski; John D Putzke; Ryan J Uitti; John A Lucas; Margaret F Turk; Bruce A Kall; Robert E Wharen
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

8.  Does deep brain stimulation induce apathy in Parkinson's disease?

Authors:  Lindsey Kirsch-Darrow; Ania Mikos; Dawn Bowers
Journal:  Front Biosci       Date:  2008-05-01

9.  Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease.

Authors:  Julian P Rodrigues; Susan E Walters; Peter Watson; Rick Stell; Frank L Mastaglia
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

10.  Deep brain stimulation and the role of the neuropsychologist.

Authors:  Michael S Okun; Ramon L Rodriguez; Ania Mikos; Kimberly Miller; Ida Kellison; Lindsey Kirsch-Darrow; Dylan P Wint; Utaka Springer; Hubert H Fernandez; Kelly D Foote; Gregory Crucian; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2007-01       Impact factor: 3.535

View more
  57 in total

1.  Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort.

Authors:  Maren C Locke; Samuel S Wu; Kelly D Foote; Marco Sassi; Charles E Jacobson; Ramon L Rodriguez; Hubert H Fernandez; Michael S Okun
Journal:  Neurosurgery       Date:  2011-05       Impact factor: 4.654

2.  Health-related quality of life as an outcome variable in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Mónica M Kurtis
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

3.  Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.

Authors:  Frances M Weaver; Kenneth A Follett; Matthew Stern; Ping Luo; Crystal L Harris; Kwan Hur; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda
Journal:  Neurology       Date:  2012-06-20       Impact factor: 9.910

Review 4.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  Site of deep brain stimulation and jaw velocity in Parkinson disease.

Authors:  Lee T Robertson; Rebecca J St George; Patricia Carlson-Kuhta; Penelope Hogarth; Kim J Burchiel; Fay B Horak
Journal:  J Neurosurg       Date:  2011-08-12       Impact factor: 5.115

6.  Swallowing outcomes following unilateral STN vs. GPi surgery: a retrospective analysis.

Authors:  Michelle S Troche; Alexandra E Brandimore; Kelly D Foote; Takashi Morishita; Dennis Chen; Karen W Hegland; Michael S Okun
Journal:  Dysphagia       Date:  2014-03-21       Impact factor: 3.438

Review 7.  Deep brain stimulation (DBS) at the interface of neurology and psychiatry.

Authors:  Nolan R Williams; Michael S Okun
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

8.  Long-term Parkinson's disease quality of life after staged DBS: STN vs GPi and first vs second lead.

Authors:  Stephanie Cernera; Robert S Eisinger; Joshua K Wong; Kwo Wei David Ho; Janine Lobo Lopes; Kevin To; Samuel Carbunaru; Adolfo Ramirez-Zamora; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  NPJ Parkinsons Dis       Date:  2020-07-06

9.  STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.

Authors:  Nolan R Williams; Kelly D Foote; Michael S Okun
Journal:  Mov Disord Clin Pract       Date:  2014-04-01

Review 10.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.